A press conference will be given by the European Medicines Agency (Coreper) on Tuesday at 15:00 Greek time, said a spokeswoman, quoted by Reuters. EMA investigates safety of AstraZeneca coronavirus vaccine after the decision of European countries such as Germany, France, Italy to suspend vaccinations due to concerns for possible side effects, such as bleeding, thrombosis and low platelet count.
And in our country there is concern and unrest for possible side effects of AstraZeneca vaccine, after temporary suspension from 17 European countries.
In Greece, its administration continues normally, as according to the National Vaccination Committee, based on the available scientific data, the discontinuation of the use of this vaccine is not justified. In fact, in its announcement, the committee points out that in cooperation with the Pharmacovigilance Committee of EOF, it gives absolute priority to the issues of vaccine safety.
Today The World Health Organization is also meeting, who decided to convene a committee of experts to examine the safety of this vaccine, although his top scientific executive recommended that it continue to be used.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
